U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536802) titled 'Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial' on April 10.
Brief Summary: Primary objective of the study is to evaluate the impact of adenosine pre-medication on incidence of slow flow/no-reflow after primary percutaneous coronary intervention.
Study Start Date: June 01, 2025
Study Type: INTERVENTIONAL
Condition:
ST-Segment Elevation Myocardial Infarction (STEMI)
No-Reflow Phenomenon
Coronary Slow Flow
Acute Myocardial Infarction
Intervention:
DRUG: Adenosine pre-medication
Patients will receive intracoronary adenosine before primary PCI in addition to standard pharmacolo...